Catalyst Event

Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Earnings Release

From Akros SCHK HK-Korea Momentum Factor Index (ASHKMOM)

4/27/2026, 12:00:00 AM

Earnings ReleaseSentiment: Positive

Biocytogen released its first-quarter 2026 report on 2026-04-27, showing revenue of about RMB 433.1 million and net profit attributable to shareholders of about RMB 104.0 million versus a loss a year earlier; likely medium positive due to the clear quarterly turnaround.

Korean Translation

2026-04-27 2026년 1분기 실적 발표로 매출 약 4.331억위안, 지배주주순이익 약 1.040억위안 기록하며 전년 동기 적자에서 흑자전환함.

Related Recent Events

View Full Timeline